Table 3.

Cost-effectiveness results of SDOCT digital surveillance in a community setting vs. HES (2015/16 prices)

		Base case (£)	Scenario 1 (£)a	Scenario 2 (£)b
SDOCT surveillance
Cost per patient	Mean=	101	101	99
	95% CI=	91–139	89–134	87–131
HES pathway
Cost per patient	Mean=	177	142	173
	95% CI=	164–219	129–179	157–209
SDOCT surveillance vs. HES pathway
Cost per patient	Mean=	−76	−41	−74
	95% CI=	−70 to −81	−37 to −46	−67 to −79

^aUnder the HES pathway, once eyes were assessed at HES for the first time after diagnosis of R1M1 at screening they would no longer require surveillance; ^bUnder both surveillance options, assuming that there was no further surveillance for SDOCT negative results if the clinic grading was R0M0 or R1M0